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Drosophila Scavenger Receptor CI
Is a Pattern Recognition Receptor for Bacteria
crobes that have been opsonized by epitope-specific
antibodies (Aderem and Underhill, 1999). It has been
proposed that pathogen-associated molecular patterns
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(PAMPs), conserved structures that adorn the surfaces1 Laboratory of Developmental Immunology
of microorganisms, are recognized by pattern recogni-MassGeneral Hospital for Children
tion molecules and receptors (Janeway, 1989). Some ofDepartment of Pediatrics
these receptors are expected to signal the presence ofHarvard Medical School
pathogens for integrated responses of the organism toBoston, Massachusetts 02114
pathogen, while others may primarily serve as endocyto-2 Department of Biology
sis/phagocytosis receptors that primarily clear, and sub-Massachusetts Institute of Technology
sequently destroy, the pathogen. Ligands can be opson-Cambridge, Massachusetts 02138
ized with soluble pattern recognition molecules such as3 Department of Medicine
complement, mannose binding proteins and lipopoly-Division of Pulmonary and Critical Care Medicine
saccharide (LPS) binding protein for subsequent inges-Beth Israel Deaconess Medical Center and
tion mediated by complement receptors, collectin re-Harvard Medical School
ceptors, and CD14, respectively (Aderem and Underhill,Boston, Massachusetts 02115
1999). In addition, macrophages can directly recognize
microorganisms via pattern recognition receptors (PRRs)
like the mannose receptor and other lectin-like receptorsSummary
(Stahl and Ezekowitz, 1998) and the scavenger receptors
(SRs) (Krieger, 1997; Gough and Gordon, 2000). ThereOne hallmark of innate immunity apparently conserved
are at least six structurally distinct classes of SRs, de-from primitive life forms through to humans is the
fined by their ability to bind acetylated and or oxidizedability of the host to recognize pathogen-associated
low-density lipoprotein (LDL) (Gough and Gordon, 2000).molecular patterns (PAMPs). Since macrophage pat-
Most classes of SRs are additionally able to recognizetern recognition receptors are not well defined in Dro-
a broad range of both common and receptor-specificsophila, we set out to identify such receptors. Our
ligands, including polyanionic compounds, apoptoticfindings reveal that Drosophila macrophages express
cells, bacteria, and LPS (Hampton et al., 1991; Ashkenasmultiple pattern recognition receptors and that the
et al., 1993; Dunne et al., 1994; Krieger, 1997).Drosophila scavenger receptor, dSR-CI, is one such
In contrast to mammalian systems, no transmem-receptor capable of recognizing both gram-negative and
brane macrophage PRR for bacteria has been unambig-gram-positive bacteria, but not yeast. Our data indicate
uously described in insects. Several soluble proteinsthat scavenger receptor bacterial recognition is con-
that recognize peptidoglycan, LPS, and -1-3-glucan,served from insects to humans and may represent one
and several complement-like proteins have been pro-of the most primitive forms of microbial recognition.
posed as pattern-recognition molecules in various inver-
tebrate species (Lee et al., 1996; Richman et al., 1997;Introduction
Kang et al., 1998; Beschin et al., 1998, Ochiai and Ashida,
1999, 2000; Ma and Kanost, 2000; Werner, et al. 2000,A consensus is emerging that the templates of innate
Levashina et al., 2001). The Drosophila gram-negativeimmunity in mammals have ancient origins (Hoffmann
binding proteins appear to participate in the induction
et al., 1999) and hence that genetically tractable model
of antimicrobial peptide synthesis in vitro, but their asso-
systems like Drosophila melanogaster can be informa-
ciation with the membrane remains uncertain (Kim et
tive in identifying genes whose products play a role in al., 2000). There are two well-characterized macrophage
the innate immunity of many species. The characteriza- receptors in Drosophila: croquemort (Franc et al., 1996)
tion of the Toll family of proteins in Drosophila and mam- and the Drosophila SR, dSR-CI (Pearson et al., 1995).
mals and their respective involvement in host defense Croquemort belongs to the CD36 superfamily of pro-
illustrates this idea (Anderson et al., 1985; Lemaitre et teins, and it is expressed specifically in macrophages.
al., 1997; Medzhitov et al., 1997). Progress in innate In vitro and in vivo experiments demonstrated a key
immunity is fueled by an interchange of experimental role for croquemort in the recognition of apoptotic cells
findings in mammalian systems with more primitive life- (Franc et al., 1996, 1999). However, macrophages lack-
forms, which indicate important similarities and differ- ing croquemort expression, while defective in apoptotic
ences (Ezekowitz and Hoffmann, 2001). cell engulfment, were still able to ingest E. coli and S.
Receptor-mediated phagocytosis of pathogens is a aureus (Franc et al., 1999). Thus, Drosophila macro-
highly conserved cellular process. Macrophages are phages must possess other PRRs for phagocytosis of
able to recognize disparate surface structures on parti- bacteria. Like croquemort, dSR-CI appears to be macro-
cles and microorganisms they ingest. One well-defined phage specific. In contrast to croquemort, dSR-CI rec-
mechanism is Fc receptor-mediated recognition of mi- ognizes a broad range of polyanionic ligands, much
like the mammalian class A SR (Pearson et al., 1995).
Comparison of the ligand binding properties of the Dro-4Correspondence: ezekowitz.alan@mgh.harvard.edu (R.A.B.E.),
mramet@partners.org (M.R.) sophila S2 cell line (Abrams et al., 1992), from which
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Figure 1. Phagocytosis of Microbes by S2 Cells and Primary Drosophila Hemocytes
(A) Phagocytosis of heat-killed, FITC-labeled bacteria by primary hemocytes from third instar larvae. Ten bacteria per cell were added to primary
hemocytes for 10 min at 26C, and the fluorescence of extracellular bacteria was quenched by the addition of Trypan blue.
(B) Phagocytosis of heat-killed, FITC-labeled E. coli, S. aureus, and C. silvatica by S2 cells after 10, 15, or 180 min of incubation, respectively.
Fluorescence of extracellular organisms was quenched by Trypan blue. Inset shows a high-magnification phase-contrast confocal microscope
image of phagocytosis of C. silvatica.
(C) Quantitation of cell-associated microbes by FACS. FITC-labeled microbes were added to S2 cells as in (B). Cell-associated microbes were
assayed by FACS (gray lines). Black line represents background autofluorescence of S2 cells.
(D) Approximately 20%–60% of the cell-associated fluorescence is due to binding since it is not cytochalasin D inhibitable. S2 cells were pretreated
for 20 min with cytochalasin D (1 g/ml) and were then incubated in the continued presence of cytochalasin D at 26C with labeled E. coli, S. aureus,
or C. silvatica for 10, 15, or 180 min, respectively. The cells were fixed and analyzed by FACS. Data shown as mean  standard error (SE).
dSR-CI was cloned, with dSR-CI expressing stably properties, we compared S2 cell and primary larval he-
transfected CHO cells suggests that Drosophila is likely mocyte (macrophage) phagocytosis. Both primary larval
to have additional SRs (Pearson et al., 1995). hemocytes (Figure 1A) and S2 cells (Figure 1B) exhibited
In this study we found that dSR-CI is a bacterial PRR phagocytosis of fluorescently labeled E. coli and S. aureus
that accounts for 20%–30% of the total bacterial binding within 15 min of particle addition. Similar results (data
activity in S2 cells. Our results suggest that SRs are not shown) were obtained using the macrophage-like
primordial PRRs and that, as in mammalian systems, mbn-2 cell line derived from third instar larval hemo-
insects have additional as yet to be defined PRRs. cytes. The phagocytosis of the yeast Candida silvatica
was less efficient in both S2 cells and primary larval
hemocytes. After 15 min, less than 5% of the cells hadResults
internalized any C. silvatica. By 3 hr, about 20% of the
S2 cells had internalized one to several C. silvatica (Fig-S2 Cell as a Model for Studying Phagocytosis
ure 1B). Zymosan was internalized poorly by S2 cells.Drosophila macrophages are capable of binding and
In order to quantitatively measure the association ofingesting both E. coli and S. aureus in vivo (Rizki and
bacteria with S2 cells, we incubated the cells for 10 orRizki 1980; Franc et al., 1999). To develop an in vitro
15 min at 26C with FITC-labeled, heat-killed bacteriacell culture system for studying phagocytosis in Dro-
and measured the fluorescence in the cells using FACS.sophila, we examined whether S2 cells were phagocyto-
In this assay, greater than 90% of the S2 cells had cell-sis competent. The S2 cells are derived from a primary
associated bacteria (Figure 1C). While this assay doesculture of late stage Drosophila embryos (Schneider,
not distinguish between binding and internalization of1972) and express macrophage-specific markers like
the bacteria, we found that 30%–50% of the cell-associ-dSR-CI and croquemort. As a first step toward evaluat-
ing whether S2 cells have macrophage-like phagocytic ated fluorescence appears to be the result of particle
dSR-CI Is a Bacterial Pattern Recognition Receptor
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Figure 2. Evidence for Common Receptors for Gram-Positive and Gram-Negative Bacteria
(A and B) Cross-competition between E. coli and S. aureus (A) and between C. silvatica, E. coli, and S. aureus (B). Ten FITC-labeled microbes per
S2 cell were incubated for 5 (A) or 180 (B) minutes in the presence or absence of unlabeled competitor. Cell-associated FITC-labeled microbes
were quantitated by FACS. Each point represents the mean  SE of two to four experiments.
(C) Inhibition profiles of E. coli, S. aureus, and C. silvatica association with S2 cells. S2 cells were incubated at 26C with labeled E. coli, S. aureus,
or C. silvatica in the presence or absence of the indicated inhibitors for 10, 15, or 180 min, respectively, and analyzed by FACS. The number of
experiments is indicated under each column. Data shown as mean  standard error. Dex-S 1 mg/ml; LTA 1 mg/ml; PolyI 500 g/ml; laminarin 10
mg/ml; AcLDL 500 g/ml; LPS 1 mg/ml.
(D) Effect of selected inhibitors on cell association of E. coli and S. aureus at 4C. S2 cells were incubated at 4C with labeled E. coli or S. aureus
in the presence of indicated inhibitors for 10 or 15 min, respectively. At least three experiments were performed with each inhibitor.
(E) Dose response curves of the effective inhibitors. S2 cells were incubated at 26C with FITC-E. coli or S. aureus in the presence of the indicated
inhibitors for 10 or 15 min, respectively. Cell-associated microbes were quantitated using FACS. Data are shown as mean  SE. Two to five
individual experiments were done for each data point.
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sophila hemocytes and S2 cells have a lower phagocyticTable 1. Effect of Various Treatments on Cell Association
of FITC-Labeled Microbes index compared to mammalian macrophages and hence
fewer unlabeled bacteria should be required for compet-Compound Concentration Yeast Bacteria
ing out binding and ingestion of labeled bacteria. Inter-
No effect estingly, unlabeled E. coli was also able to compete for
Asialofetuin 10 mg/ml – ND
the cell association of labeled S. aureus, and unlabeledChitin 0.5 mg/ml – ND
S. aureus was able to compete for labeled E. coli. Impor-Dextran 10 mg/ml – –
tantly, neither E. coli nor S. aureus were able to inhibit theEDTA 10 mM – –
EGTA 20 mM – ND cell association of FITC-C. silvatica (Figure 2B). These
Fructose 100 mM – ND results suggest that there may be a common receptor(s)
D-Fucose 100 mM – – for E. coli and S. aureus and a distinct receptor(s) for
L-Fucose 100 mM – –
C. silvatica.Galactose 100 mM – –
In order to further test this hypothesis, a variety ofN-Acetyl-Galactosamine 100 mM – ND
molecules were tested for their ability to inhibit binding-Glucan 1.0 mg/ml – ND
Glucose 100 mM – – and phagocytosis of E. coli, S. aureus, and C. silvatica.
N-Acetyl-Glucosamine 100 mM – – Of the many potential inhibitors tested (Table 1), only a
HDL 0.5 mg/ml – – few appeared to have an effect. Dextran sulfate (Dex-S)
Heparinase I 5 U/105 S2 cells – –
and fucoidan inhibited the cell association of all threeLactose 100 mM – ND
microorganisms (Figure 2C). In contrast, several otherLDL 0.5 mg/ml – –
inhibitors were more selective. Polyinosinic acid (polyI),LPS 1.0 mg/ml – –
Maltose 100 mM – ND acetylated LDL (AcLDL), laminarin, and lipoteichoic acid
Mannose 100 mM – – (LTA) were all inhibitors of bacterial, but not yeast, asso-
N-Acetyl-Mannosamine 100 mM – – ciation with S2 cells (Figure 2C). The effects of polyI,
Polycytidylic acid (PolyC) 0.5 mg/ml – –
LTA, and laminarin are probably due primarily to compe-
Nonselective inhibition tition with the bacteria for receptor binding since these
Chondroitin sulphate 25 mg/ml ↓ ↓↓
compounds reduced the binding of bacteria to S2 cellsCytochalasin-D 10 g/ml ↓↓ ↓↓
at 4C (Figure 2D). For those compounds that did notDextran sulphate 10 mg/ml ↓↓ ↓↓
inhibit binding, we indicate the highest concentrationsFetuin 10 mg/ml ↓ ↓
Fucoidan 10 mg/ml ↓↓ ↓↓ used (Table 1). Inhibition of bacterial binding was dose
Heparin 100 U/ml ↓ ↓ dependent for all effective inhibitors (Figure 2E). Inter-
Neuraminic acid 25 mM ↓↓ ↓ estingly, we observed a difference in efficacy among
Selective inhibition the bacteria-specific inhibitors of S2 cell association:
Acetylated LDL 0.5 mg/ml – ↓ whereas polyI inhibited cell association of bacteria al-
Laminarin 10 mg/ml – ↓
most completely, both laminarin and AcLDL were partialLipoteichoic acid 1.0 mg/ml – ↓↓
inhibitors (Figures 2C–2E). These results suggest thatPolyinosinic acid (Polyl) 0.5 mg/ml – ↓↓
there is more than one bacteria-specific phagocytic re-
–, cell association 75%–125% of control; ↓, 50%–75% of control; ↓↓, ceptor in Drosophila in addition to distinct receptor(s)
50% of control; ND, not determined. Bacteria represent E. coli
for C. silvatica.and/or S. aureus. No significant differences were observed between
Although LTA is a cell wall component of gram-posi-gram-negative and gram-positive bacteria.
tive bacteria, it was also a very effective inhibitor of
binding of gram-negative bacteria. This effect was spe-
cific since, in addition to having no effect on the associa-
internalization as it is inhibitable by prior treatment of tion of yeast with S2 cells, LTA had no effect on latex
S2 cells with cytochalasin D (Figure 1D), an inhibitor of bead phagocytosis or on endocytosis of FITC-BSA (data
actin polymerization. Taken together, these results indi- not shown). Similar results were obtained with primary
cate that phagocytosis by S2 cells is similar to phagocyto- larval hemocytes (on average 3.8 FITC- E. coli per cell
sis by primary larval hemocytes of Drosophila and that, were phagocytosed by untreated cells compared to 0.5
as in mammalian systems, both cell types use actin by cells treated with 1 mg/ml LTA), indicating that the
polymerization-dependent phagocytic mechanisms. inhibition was not an artifact due to the use of a cultured
cell line. The ability of S. aureus-derived LTA to inhibit
gram-positive and gram-negative bacterial binding isInhibition Profiles of Drosophila PRRs for Microbes—
contrasted with the failure of E. coli-derived LPS to actEvidence for Common Receptor(s) for Gram-Positive
as an inhibitor of either S. aureus or E. coli associationand Gram-Negative Bacteria
(Figure 2C). As unlabeled whole E. coli were effectiveIn order to determine whether E. coli and S. aureus were
inhibitors, this suggests that the failure of soluble LPSrecognized by the same or distinct S2 cell PRRs, we
to act as an inhibitor is either an in vitro artifact orperformed cross-competition experiments. As shown in
that other components of the gram-negative bacterialFigure 2A, unlabeled S. aureus competed for the cell
membrane, with or without LPS, are required.association of FITC-labeled S. aureus in a dose-depen-
dent manner. A similar result was observed for E. coli.
Coincubation of 10 labeled bacteria with 10 unlabeled dSR-CI Is a Candidate PRR for Bacteria
The inhibitor profile of S2 cell binding and phagocytosisbacteria/S2 cell resulted in 20%–40% inhibition (i.e., 1
in Figure 2A); 100 unlabeled to 10 labeled bacteria re- of bacteria is similar to the known ligand specificities of
both the mammalian class A SRs and the macrophage-sults in 70%–90% inhibition (i.e., 10 in Figure 2A). Dro-
dSR-CI Is a Bacterial Pattern Recognition Receptor
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Figure 3. dSR-CI Is a Potential Candidate Receptor for Bacteria
(A) Schematic representation of SR-Cs indicating different domains. MAM, a domain found in Meprin, A5 antigen, and RPTP Mu. CCP, complement
control protein domain.
(B) Developmental expression analysis of the SR-C family by Northern blot. Each dSR-C has a unique expression profile, only dSR-CI being
expressed throughout development. L, larvae; EP, early pupae; LP, late pupae; M, adult male; F, adult female.
(C) Polymorphic nucleotides of dSR-CI.
specific Drosophila SR, dSR-CI (Pearson et al., 1995; derived from S2 cells (Figure 3C). These SNPs indicate
a level of diversity that is sometimes associated withKrieger, 1997). dSR-CI is the defining member of a small
family of proteins in Drosophila. We identified two addi- host defense molecules.
tional dSR-C family members by genomic and cDNA
cloning, while a homology search against all known Dro- dSR-CI Binds Both Gram-Positive and Gram-Negative
Bacteria and Is Necessary for Optimal Phagocytosissophila genes and ESTs identified a fourth member. All
four molecules (shown schematically in Figure 3A) have of Bacteria by S2 Cells
In order to determine if dSR-CI expression is sufficienttwo N-terminal complement control protein (CCP) do-
mains followed by a MAM domain. dSR-CI, dSR-CII, and for cells to bind E. coli and/or S. aureus, we tested the
bacterial binding capability of a stably transfected CHOdSR-CIV then have a somatomedin B domain and dSR-CI
and dSR-CII further have Ser/Thr-rich, transmembrane, cell line expressing dSR-CI (CHO[dSR-CI]) (Pearson et
al., 1995). CHO[dSR-CI] cells were able to bind bothand cytoplasmic domains. dSR-CIII and dSR-CIV are
predicted to encode secreted proteins. E. coli (Figure 4A) and S. aureus (Figure 4B) but not
C. silvatica or latex beads (data not shown). While thereSeveral experiments were performed in order to gain
insight into which of the dSR-Cs might be candidate was avid bacterial binding to transfected cells, there was
little ingestion of the bound bacteria (data not shown).PRR for bacteria. First, conditioned media from S2 cells
did not affect binding or ingestion of bacteria, sug- Untransfected CHO cells bound neither E. coli (data not
shown) or S. aureus (Figure 4C). The uptake of labeledgesting that secreted proteins like dSR-CIII or dSR-CIV
are unlikely to play a role in this process under our assay AcLDL is an accepted measure of SR activity in S2 cells
(Pearson et al., 1995). For this reason we determinedconditions (data not shown). Second, developmental
analysis of dSR-C gene expression (Figure 3B) showed that dSR-CI CHO transfectants (Figure 4A), but not mock
transfectants, internalized DiI-AcLDL, and therefore wethat dSR-CI is expressed throughout the life cycle of
the fly from early embryogenesis to adults. Furthermore, conclude that these transfectants express functional
dSR-CI. There was a positive correlation between thedSR-CI exhibits hemocyte-specific expression in the
embryo (Pearson et al., 1995), is expressed in the larval level of DiI-AcLDL uptake and the amount of bacterial
binding in this population of CHO[dSR-CI] cells that ex-hemocyte-derived mbn-2 cells (Dimarcq et al., 1997),
and its expression is induced at the onset of pupariation, hibited a somewhat heterogeneous distribution of dSR-CI
expression. Those cells that efficiently endocytosedperhaps to aid in the phagocytic clearance of cell
corpses and debris generated during metamorphosis AcLDL also bound bacteria (white arrows in Figures 4A
and 4B), while those cells that were unable to take up(Lanot et al., 2001). In contrast, dSR-CII is expressed
only in the embryo from 2 to 8 hr after egg laying and AcLDL had, like the untransfected CHO cells, few or no
bound bacteria (gray arrows in Figure 4A).with no apparent hemocyte expression (Figure 3B and
data not shown). Interestingly, sequencing of the Oregon We also performed similar experiments on COS cells
transiently transfected with the dSR-CI cDNA. AlthoughR genomic DNA encoding dSR-CI revealed 16 single
nucleotide polymorphisms (SNPs), 5 of which are non- there is significant background binding of FITC-labeled
bacteria to untransfected COS cells (data not shown),conservative, compared to the sequence of the cDNA
Immunity
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Figure 4. CHO and COS-7 Cells Transfected with dSR-CI Bind Both S. aureus and E. coli
(A and B) Confocal images of dSR-CI-expressing CHO cells (CHO[dSR-CI]) incubated with FITC-labeled E. coli (A) or S. aureus (B) for 20 min and
thereafter 20 min with DiI-AcLDL (5 g/ml). Prior to fixing, cells were washed five times with 1xPBS. (A) Top left panel, Nomarski optics. Rhodamine
channel shows DiI-AcLDL in red (top right). FITC channel shows FITC-E. coli in green (bottom left). Overlay of Rhodamine and FITC channels shown
in bottom right panel. (B) Left panel, Nomarski optics. Right panel, overlay of rhodamine channel showing DiI-AcLDL in red and FITC channel
showing FITC-S. aureus in green.
(C) Confocal images of untransfected CHO cells incubated for 20 min with FITC-labeled S. aureus followed by washes as in (A). Left panel, Nomarski
optics. Right panel, FITC channel showing FITC-S. aureus in green.
(D) FACS analysis of FITC-E. coli and FITC-S. aureus binding to mock-transfected (gray diagram) and to dSR-CI transfected (transparent diagram)
COS-7 cells after 20 min incubation with FITC-labeled bacteria. Prior to analysis, cells were washed as in (A).
(E) Inhibition profile of FITC-E. coli binding to dSR-CI. CHO[dSR-CI] and untransfected CHO cells were incubated with FITC-labeled E. coli for 20
min in the presence of the indicated competitor. Cells were washed five times with 1xPBS and fixed with 1% paraformaldehyde. Cell-associated
microbes were quantitated by FACS. The amount of dSR-CI-dependent cell association of FITC-E. coli was calculated by subtracting the background
binding of parent CHO cells from total binding by CHO[dSR-CI] cells. Each column represents mean SE of two to four experiments. Dex-S 1 mg/
ml; LTA 1 mg/ml; PolyI 500 g/ml; Laminarin 10 mg/ml; AcLDL 500 g/ml; LDL 500 g/ml; Polycytidylic acid 500 g/ml; LPS 1 mg/ml.
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the results shown in Figure 4D demonstrate that dSR-CI In order to determine if the dsRNA treatment elimi-
nated all dSR-CI activity in S2 cells, we examinedtransfectants clearly exhibited enhanced E. coli and
S. aureus binding (solid line) compared to mock-trans- whether a specific dSR-CI inhibitor would enhance the
effect of dsRNA treatment in S2 cells. The addition offected COS cells (shaded lines) or COS cells transfected
with the croquemort cDNA (data not shown). AcLDL to dSR-CI dsRNA-treated S2 cells did not en-
hance the effect of dsRNA treatment alone (Figure 5E),The inhibition profile for dSR-CI-dependent E. coli
binding to CHO[dSR-CI] cells (Figure 4E) was compared indicating that the dsRNA treatment effectively blocked
most of the dSR-CI-dependent bacterial cell associa-to that observed with S2 cells. As with S2 cells, Dex-S,
polyI, and LTA were effective inhibitors of E. coli cell tion. This result lends further support to the hypothesis
that the residual binding activity observed when treatingassociation with dSR-CI, while LPS was a poor inhibitor
(compare Figures 2B and 4E). Of note, laminarin (10 mg/ cells with AcLDL is likely due to one or more PRRs
distinct from dSR-CI.ml) and AcLDL (500 g/ml), which are avid ligands of
dSR-CI, almost totally inhibited dSR-CI-dependent
E. coli binding to CHO[dSR-CI] cells, whereas these dSR-CI Does Not Appear to Be Required
for the Antibacterial Peptide Responsecompounds were only partial inhibitors of E. coli binding
to S2 cells (compare Figures 2B and 4I). This result Triggered by Bacteria in S2 Cells
Secretion of antimicrobial peptides as a response tosuggests again that additional receptors beyond dSR-CI
play a role in bacterial binding to S2 cells. microbial challenge is one of the cornerstones of innate
immunity (Steiner et al., 1981; Lehrer and Ganz, 1999).To demonstrate direct binding of bacteria, and to de-
fine the binding site in more detail, we created three While the Toll antifungal pathway is now well defined in
Drosophila (Lemaitre et al., 1997; Imler and Hoffmann,recombinant soluble forms of the receptor (Figure 4F).
All of these soluble receptors bound E. coli and S. aureus, 2000), it is not yet clear how bacteria trigger antibacterial
responses. At least one genetically defined pathway,but not C. silvatica or latex beads (Figure 4F shows results
of full-length secreted ectodomain and a construct encod- termed the immune deficiency (IMD) pathway, appears
to account for most antibacterial peptide (e.g., attacin)ing the MAM and CCP domains). Based on these results,
we conclude that the CCP domains together with the gene induction (Imler and Hoffmann, 2000). However,
none of the Drosophila Toll-related receptors appear toMAM domain are sufficient to bind bacteria in vitro,
whereas the Ser/Thr-rich domain and somatomedin B be involved in the regulation of the antibacterial genes
(Tauszig et al., 2000). To determine if dSR-CI triggersdomain are not essential. Further domain analysis was
hampered by the fact that removal of the first CCP domain the induction of antimicrobial genes in S2 cells, we used
an attacin promotor-driven luciferase reporter geneyielded a protein that was trapped inside the cell. There-
fore, a more directed mutagenesis is required to define (Tauszig et al., 2000), since attacin expression is con-
trolled entirely by the IMD pathway (Imler and Hoffmann,the minimal effective binding domains.
To more directly explore the role of dSR-CI in S2 cell 2000). As shown in Figure 6, a 12 hr incubation of S2
cells with E. coli resulted in an approximately 10-foldbinding and phagocytosis of E. coli and S. aureus, we
utilized dsRNAi-mediated gene silencing, an effective increase in attacin-reporter activity. Incubation with
S. aureus had a similar effect (data not shown). dsRNA-method to diminish protein expression in Drosophila and
in S2 cells (Kennerdell and Carthew, 1998; Hammond et mediated silencing of dSR-CI expression did not reduce
luciferase induction, suggesting that dSR-CI is not nec-al., 2000). dMoesin, an abundant membrane-associated
protein, was used as a control in all of the dsRNAi experi- essary for the attacin response in S2 cells. Furthermore,
transfection of S2 cells with the dSR-CI cDNA did notments. Using semiquantitative RT-PCR (Figure 5A), we
found that dSR-CI and dMoesin transcript levels were induce luciferase activity in the absence of bacteria,
nor did it superinduce luciferase activity in response tostrongly and specifically decreased 96 hr after treatment
with dSR-CI or dMoesin dsRNA, respectively (Figure E. coli (Figure 6) or S. aureus (data not shown). These
results indicate that dSR-CI is not necessary for attacin5B). The decreases in mRNA expression were accompa-
nied by corresponding decreases in protein levels as gene induction in S2 cells.
determined on Western blots (Figure 5C). When tested
for their ability to bind and engulf bacteria, S2 cells Discussion
treated with dSR-CI dsRNA exhibited a 20%–30% re-
duction in the level of E. coli and S. aureus cell associa- The use of genetically tractable model systems like Dro-
sophila has proven invaluable in defining necessarytion as compared to untreated cells (Figure 5D). In con-
trast, treatment of S2 cells with dMoesin dsRNA or sham genes and pathways that play a role in innate host de-
fense. However, unlike mammalian systems, there is aRNA had no significant effect on bacterial cell associa-
tion (Figure 5D). None of the dsRNAi treatments affected paucity of well-characterized Drosophila cell lines. Of
the Drosophila cell lines, the embryo-derived S2 cell lineC. silvatica association to S2 cells (Figure 5D).
(F) Secreted dSR-CI constructs bind E. coli and S. aureus but not C. silvatica or latex beads. Two different secreted forms of dSR-CI (as
shown schematically in the figure) were expressed in COS-7 cells for 36 hr, and cell culture medium (containing 0.1% serum) was collected
for in vitro binding assay; 100 g of E. coli, S. aureus, C. silvatica, or latex beads were added in 400 l of the medium and incubated 1 hr at
4C with mild agitation. Thereafter the mixture was centrifuged and the pellet was washed five times with 1 ml of 1xPBS. dSR-CI protein
bound to the pellet was detached by adding 50 l of SDS-PAGE loading buffer, boiled for 10 min, and visualized by Western blot using dSR-
CI antibody against the MAM domain. First lane of each construct, 20 l of the medium. Following lanes, 400 l of medium incubated for 1
hr with 100 g of indicated ligand.
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is the most widely used. Several markers that define
Drosophila macrophages in vivo, including peroxidasin,
croquemort, and dSR-CI, are expressed in S2 cells. We
have found that S2 cells are similar to primary larval
macrophages in their ability to phagocytose C. silvatica,
E. coli, and S. aureus. S2 cell phagocytosis of bacteria
is rapid and, like mammalian macrophage phagocytosis,
is cytochalasin sensitive. These results provide strong
support that S2 cells should be considered macro-
phage-like and that they represent a valid in vitro model
system to study phagocytosis in Drosophila. This will
likely complement and inform more traditional in vivo
genetic studies.
Using S2 cells we have identified the Drosophila SR,
dSR-CI, as a PRR for E. coli and S. aureus. This conclu-
sion is based on several findings. First, cross-competi-
tion studies indicate that S2 cells are likely to have a
common receptor(s) for gram-positive and gram-nega-
tive bacteria. Second, inhibition profiles of cell associa-
tion of both E. coli and S. aureus were similar to each
other and to the known ligand specificities of both the
mammalian type A SRs (Hampton et al., 1991; Ashkenas
et al., 1993; Fraser et al., 1993; Dunne et al., 1994) and
dSR-CI (Pearson et al., 1995). Third, mammalian CHO
and COS cells transfected with dSR-CI as well as se-
creted dSR-CI constructs selectively bind E. coli and
S. aureus. Finally, association of both E. coli and
S. aureus with S2 cells was reduced by 25% when ex-
pression of dSR-CI was abolished by RNAi treatment.
Therefore, dSR-CI appears necessary for optimal
phagocytosis/binding of both gram-negative and gram-
positive bacteria by S2 cells.
Comparisons between CHO[dSR-CI] and S2 cells in
our initial study (Pearson et al., 1995) suggested that S2
cells might have multiple SRs. Our current results are
reminiscent of these findings in that almost all binding
of E. coli to CHO[dSR-CI] was inhibited by AcLDL and
laminarin, whereas these compounds had only partial
inhibitory effect on association of bacteria to S2 cells.
Furthermore, dSR-CI RNAi-treated S2 cells had a 25%
reduction in cell association of bacteria, and this could
not be further inhibited by addition of AcLDL. This ar-
gues that there are other bacterial PRRs in S2 cells. In
addition, C. silvatica appears to be recognized differ-
ently from bacteria based on the distinct inhibition pro-
Figure 5. dSR-CI Is Necessary for Optimal Binding/Phagocytosis of file and cross-competition results.
Bacteria A common feature of the expanding family of SRs is
(A) Semiquantitative RT-PCR to estimate mRNA levels of dMoesin their ability to bind a broad range of polyanionic ligands.
and dSR-CI. Lane 1, size standards. Lanes 2–4, dMoesin RT-PCR Mammalian SR-AI and SR-AII recognize E. coli-derived
using 1 (lane 2), /10 (lane 3), or /100 (lane 4) dilutions of S2 cell bacterial LPS and its bioactive precursor, lipid IVA, aslysate as a template. S2 cell lysate was diluted to cell lysate (CHO)
well as S. aureus and its outer cell wall component lipo-that did not contain dMoesin or dSR-CI mRNA. Lanes 5–7, corre-
sponding experiment for dSR-CI. Lane 8, dSR-CI and dMoesin PCR, teichoic acid (Hampton et al., 1991; Ashkenas et al.,
no template. 1993; Dunne et al., 1994). It is of interest that different
(B and C) dsRNAi-mediated gene silencing specifically decreases bacterial strains of E. coli are recognized differently by
both RNA (B) and protein (C) levels of the target protein. Representa-
tive dMoesin, dSR-CI, and dActin RT-PCR shown in (B) and dSR-
CI and dMoesin Western blot in (C). 10 g of dsRNA was added to
1.0  106 cells, and the cells cultured for 96 hr. Equivalent amounts
C. silvatica were used per cell. Number of experiments is shownof total protein were loaded to each lane based on OD545. Immunode-
tection of dMoesin and dSR-CI was performed on the same blot. below each column. Each of these experiments consists of two to
four independent assays. Error bars represent SE. Sham, RNA of(D) FACS quantitation of microbe S2 cell association in the presence
or absence of dsRNA treatment. 1.0  106 cells were incubated for non-Drosophila origin. *, p  0.05; **, p  0.01.
(E) The effect of AcLDL (500 g/ml) and dSR-CI RNAi on association96 hr with 10 g of dsRNA and subsequently for 5 min with FITC-
labeled E. coli, for 10 min with FITC-S. aureus, or for 2 hr with FITC- of FITC-labeled E. coli with S2 cells. Each column represents the
mean of two to four experiment  SE.C. silvatica and analyzed by FACS. Twenty-five bacteria or ten
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Figure 6. dSR-CI Is Not Required for E. coli-
Induced Attacin Expression in S2 Cells
S2 cells were incubated for 12 hr with 1.0 
107 E. coli. Attacin reporter activity was quan-
titated using a luciferase assay as described
in Experimental Procedures. dSR-CI trans-
fection was performed 36 hr prior to addition
of E. coli. dSR-CI dsRNAi treatment was per-
formed as described in Figure 5. Each experi-
ment was repeated twice using both E. coli
and S. aureus as elicitors with similar results.
In each experiment, two to four independent
assays were done for each condition. A repre-
sentative experiment is shown. Error bars
represent SE.
SR-A and that gram-negative bacteria express other— 16 SNPs compared to the sequence of the cDNA derived
from S2 cells. Even more extensive polymorphisms haveyet incompletely characterized—SR ligands (Peiser et
al., 2000). Microbial binding activity may indeed reflect been observed in dSR-CI in wild populations of Drosophila
melanogaster and Drosophila simulans (T. Schlenke andphysiologically relevant roles of SR-AI and SR-AII in
innate host defense as SR-A/ mice are more suscepti- D. Begun, personal communication). These variations
are consistent with dSR-CI playing a role in pattern rec-ble to infection with Listeria monocytogenes, S. aureus,
and Herpes simplex virus type1 compared to their wild- ognition in host defense because high-frequency poly-
morphism would be expected to confer some individualtype littermates (Suzuki et al., 1997; Thomas et al., 2000).
The precise role of SR-AI and SR-AII in the control of variation in capacity to recognize pathogens, a property
well established with major histocompatibility loci in theinflammatory response is currently unclear. (Haworth et
al., 1997; Kobayashi et al., 2000). A third class A adaptive immune system. Interestingly, significant varia-
tions in the coding sequences in the SR-AI/II gene haveSR, macrophage receptor with collagenous structure
(MARCO), has also been found to bind E. coli and also been reported in mice (Fortin et al., 2000; Daugherty
et al., 2000). Although the functional significance of theseS. aureus (Elomaa et al., 1995). The other class of mam-
malian bacteria binding SRs is represented by LOX-1, changes is not yet clear, it is interesting to speculate
that, like variants in other host defense molecules suchwhich is expressed on vascular endothelial cells and
was recently shown to support adhesion of E. coli and as the mannose binding lectin, the surfactant apopro-
teins, and human Toll receptor, these may all generateS. aureus (Shimaoka et al., 2001). In spite of similar
ligand binding properties, the SR-As and LOX-1 are subtle differences in the host response to infection
(Turner and Hamvas, 2000; Ra¨met et al., 2001; Arbourstructurally distinct. The class A SRs are trimeric type
II membrane proteins that bind their ligands via their et al., 2000).
Our thesis is that pattern recognition is a cornerstonecollagen-like domains (Kodoma et al., 1990; Rohrer et
al., 1990; Acton et al., 1993; Doi et al., 1993; Elomaa et of innate immunity and that this concept has been con-
served from the most primitive multicellular organismsal., 1995), while LOX-1 has a C-type lectin-like structure
(Shimaoka et al., 2001). Based on the results shown in to humans. Accordingly, it appears that polyanionic li-
gands represent one basic pattern and hence that SRsthis study, dSR-CI can be now added to SRs with bacte-
ria binding properties. Again, dSR-CI bears no structural having a broad range of polyanionic ligand binding spec-
ificity have been maintained throughout evolution. Ourhomology to mammalian SRs. Our data show that dSR-
CI is not required for antibacterial peptide (attacin) re- in vitro results indicate that SRs appear to be involved
in recognition of bacteria in invertebrates, providing asponse triggered by E. coli or S. aureus. Additional stud-
ies will be required to determine if dSR-CI is required further example of functional conservation of innate im-
munity from insects to mammals. We therefore postulatefor the induction of host defense responses initiated by
other elicitors. that SRs represent primordial pattern recognition mole-
cules and that they may mediate evolutionarily con-In this study we demonstrated that there are three
additional members in the Drosophila class C SR family. served innate immunity linked functions.
dSR-CII is predicted to be a transmembrane protein,
whereas dSR-CIII and dSR-CIV appear to be secreted. Experimental Procedures
dSR-CI is expressed throughout the life cycle of the fly,
Cell Culture and Isolation of Primary Hemocyteswhile dSR-CII expression was detected only in very early
Schneider S2 cells (S2 cells) and mammalian CHO and CHO[dSR-CI]embryos, making it unlikely that dSR-CII would have any
(clone 2.6a) cells were maintained as described earlier (Pearson et al.,
significant role in innate immunity at later stages of Dro- 1995). COS-7 cells were maintained in Dulbecco’s modified Eagle’s
sophila development. In the course of this study, we se- medium with 4 mM L-glutamine adjusted to contain 1.5 g/l sodium
bicarbonate, 4.5 g/l glucose, and 1.0 mM sodium pyruvate and 10%quenced genomic DNA encoding dSR-CI and identified
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FCS. For isolation of primary hemocytes, third instar larvae were simultaneously from a single PCR product using the T7 MegaScript
RNA polymerase (Ambion, Austin, TX). DNAase-treated dsRNA waswashed briefly in 5% sodium hypochlorite and thereafter twice in
water. Hemocytes were obtained from groups of four larvae opened analyzed by agarose gel electrophoresis. The concentration of
dsRNA was 10 g per 106 S2 cells in each experiment. Cells werewith forceps into 300l Shields and Sang M3 insect medium (Sigma,
St Louis, MO) in 96-well ultralow-adhesion plates (Costar). incubated with dsRNA under serum-free conditions for 30 min be-
fore adding FCS.
Fluorescence Microscopy and Determining Phagocytic Index
Antibody Production and Western BlottingApproximately 10 heat-killed, FITC-labeled microbes (Molecular
A synthetic peptide containing amino acids RRPWKRVSTVSDIHSLRProbes, Eugene, OR) per cell (unless stated otherwise) were added
TGPRHC of the MAM domain of dSR-CI was coupled to KLH asto cells in serum-free medium in tissue culture plates, which were
previously described (Kozarsky et al., 1986) and used to generate athen centrifuged 2 min at 100  g and incubated for the indicated
rabbit polyclonal antiserum that specifically recognizes the dSR-CItime at 26C. The fluorescence of extracellular particles was
protein (data not shown). A mouse polyclonal dMoesin antibody wasquenched by replacing the medium with 0.2% Trypan blue in 1xPBS
a generous gift from Dr R. Fehon (Department of Botany and Zoology,(pH 5.5), and the cells were analyzed by fluorescence microscopy.
Duke University, Durham, NC), and was used at 1:10,000 concentration.The phagocytic index is determined as the number of particles giving
Western blot detection was conducted using the Renaissance chemilu-bright fluorescence per cell.
minescence reagent (Life Science, Boston, MA).
Confocal Microscopy
Luciferase Reporter AssayA Leica confocal laser scanning microscope consisting of a Leica
Attacin-reporter activity was measured essentially as described earlierTCS 4D scanner attached to a Leitz DMBR/E microscope was oper-
(Tauszig et al. 2000). In brief, 1.0  106 S2 cells were transfected withated using the TCS-NT software.
1.0 g of attacin-reporter plasmid and -galactosidase expression
vector (Tauszig et al., 2000) and with 1.0g of the experimental expres-FACS Analysis to Quantitate Cell-Associated Microbes
sion plasmid using Superfect (Qiagen). When dsRNAi was used, 15S2 cells were incubated for the indicated time with FITC-labeled,
g of dsRNA was added 6 hr after the initial transfection. After 48 hr,heat-killed E. coli, S. aureus, or C. silvatica in Schneider’s medium
cells were treated as indicated, washed with 1xPBS, and lyzed inwithout serum or antibiotics, then fixed with 1% paraformaldehyde
reporter lysis buffer (Promega). Luciferase and -galactosidase activi-in 1xPBS, and subsequently analyzed with FACS using the CELL-
ties were measured using Promega Luciferase assay system andQuest program (Becton Dickinson) or System II (Coulter). S2 cells
Tropix Galacton-Plus substrate, respectively. -galactosidase activityshowing increased fluorescence were gated as shown in Figure
was used to normalize transfection efficiency.1C. The level of microbe cell association was quantitated as the
percentage of fluorescence positive cells multiplied by the mean
Statistical Analysisfluorescence of these cells, and 3,000–10,000 cells were counted
Data were analyzed using one-way ANOVA. p 0.05 was consideredfrom each sample. All inhibitors were added 20 min prior to the
to be significant.addition of FITC-labeled ligand. All compounds tested for an inhibi-
tory effect on microbe cell association were purchased from Sigma
Acknowledgmentsunless stated otherwise. LDL and HDL were isolated as previously
described (Hannuksela et al., 1996). Fluorescent 1,1-dioctadecyl-
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